BioPlus Acquisition (BioPlus Acquisition) Current Accrued Expense : $0.41 Mil (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is BioPlus Acquisition Current Accrued Expense?

BioPlus Acquisition's Current Accrued Expense for the quarter that ended in Jun. 2023 was $0.41 Mil.

BioPlus Acquisition's quarterly Current Accrued Expense declined from Dec. 2022 ($0.26 Mil) to Mar. 2023 ($0.23 Mil) but then increased from Mar. 2023 ($0.23 Mil) to Jun. 2023 ($0.41 Mil).

BioPlus Acquisition's annual Current Accrued Expense increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.18 Mil) and increased from Dec. 2021 ($0.18 Mil) to Dec. 2022 ($0.26 Mil).

BioPlus Acquisition Current Accrued Expense Historical Data

The historical data trend for BioPlus Acquisition's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPlus Acquisition Current Accrued Expense Chart

BioPlus Acquisition Annual Data

Trend

Dec21

Dec22

Current Accrued Expense

0.18

0.26

BioPlus Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Current Accrued Expense	Get a 7-Day Free Trial					0.24	0.29	0.26	0.23	0.41

BioPlus Acquisition Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

BioPlus Acquisition Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of BioPlus Acquisition's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.